CELF4
CUGBP Elav-like family member 4
Also known as: BRUNOL4, CELF4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BZC1
- Gene
- CELF4
- Ensembl
- ENSG00000101489
- Chromosome
- 18
- Canonical length
- 486 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Members of the CELF/BRUNOL protein family contain two N-terminal RNA recognition motif (RRM) domains, one C-terminal RRM domain, and a divergent segment of 160-230 aa between the second and third RRM domains. Members of this protein family regulate pre-mRNA alternative splicing and may also be involved in mRNA editing, and translation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
486 residues, UniProt reviewed canonical sequence.
>Q9BZC1|CELF4
1 MYIKMATLAN GQADNASLST NGLGSSPGSA GHMNGLSHSP GNPSTIPMKD HDAIKLFIGQ
61 IPRNLDEKDL KPLFEEFGKI YELTVLKDRF TGMHKGCAFL TYCERESALK AQSALHEQKT
121 LPGMNRPIQV KPADSESRGG SSCLRQPPSQ DRKLFVGMLN KQQSEDDVRR LFEAFGNIEE
181 CTILRGPDGN SKGCAFVKYS SHAEAQAAIN ALHGSQTMPG ASSSLVVKFA DTDKERTMRR
241 MQQMAGQMGM FNPMAIPFGA YGAYAQALMQ QQAALMASVA QGGYLNPMAA FAAAQMQQMA
301 ALNMNGLAAA PMTPTSGGST PPGITAPAVP SIPSPIGVNG FTGLPPQANG QPAAEAVFAN
361 GIHPYPAQSP TAADPLQQAY AGVQQYAGPA AYPAAYGQIS QAFPQPPPMI PQQQREGPEG
421 CNLFIYHLPQ EFGDAELMQM FLPFGFVSFD NPASAQTAIQ AMNGFQIGMK RLKVQLKRPK
481 DANRPYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CELF4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 94 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 94 nTPM
- cerebral cortex: 92 nTPM
- hypothalamus: 73 nTPM
- amygdala: 71 nTPM
- basal ganglia: 68 nTPM
- hippocampal formation: 58 nTPM
Single-cell type
- retinal amacrine cells: 865 nCPM
- retinal horizontal cells: 413 nCPM
- other brain neurons: 372 nCPM
- brain inhibitory neurons: 367 nCPM
- somatotrophs: 367 nCPM
- brain excitatory neurons: 342 nCPM
Immune cell
- basophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 235 nTPM
- basal ganglia: 205 nTPM
- white matter: 186 nTPM
- hypothalamus: 163 nTPM
- hippocampal formation: 163 nTPM
- amygdala: 152 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.23
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.16
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- alternative mRNA splicing, via spliceosome
- embryo development ending in birth or egg hatching
- excitatory postsynaptic potential
- germ cell development
- in utero embryonic development
- mRNA splice site recognition
- negative regulation of excitatory postsynaptic potential
- negative regulation of mRNA splicing, via spliceosome
- positive regulation of mRNA splicing, via spliceosome
- regulation of alternative mRNA splicing, via spliceosome
- regulation of retina development in camera-type eye
Molecular functions
- BRE binding
- mRNA binding
- mRNA regulatory element binding translation repressor activity
- pre-mRNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CELF4 as an antibody target. Whether an autoantibody or antibody against CELF4 could matter depends on whether native CELF4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CELF4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CELF4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...